Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms - PubMed (original) (raw)

Comparative Study

doi: 10.1007/s00125-005-1682-x. Epub 2005 Mar 4.

Affiliations

Comparative Study

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

E Bugianesi et al. Diabetologia. 2005 Apr.

Abstract

Aims/hypothesis: Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.

Methods: We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.

Results: In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.

Conclusions/interpretation: Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1989 Aug;84(2):458-67 - PubMed
    1. Nutrition. 1993 Sep-Oct;9(5):452-9 - PubMed
    1. Hepatology. 2003 Apr;37(4):917-23 - PubMed
    1. Diabetes. 2000 May;49(5):701-7 - PubMed
    1. Jpn J Med. 1988 May;27(2):142-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources